CONCLUSIONS: Benzodiazepine exposure is common among adolescents and young adults. Prevalence appears context-dependent, likely reflecting differences in prescribing practices, access pathways, and exposure measurement across settings. These findings highlight the importance of developmentally tailored prescribing guidelines and suggest that expanding non-pharmacological alternatives may be warranted in this population.
